ARVN

$0.00

(

+0.00%

)
Quote details

stock

Arvinas Inc

NASDAQ | ARVN

9.80

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$694.53M

Market Cap

-

P/E Ratio

-1.01

EPS

$29.61

52 Week High

$5.90

52 Week Low

HEALTHCARE

Sector

ARVN Chart

Recent Chart
Price Action

ARVN Technicals

Tags:

ARVN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $263M
Total Revenue $263M
Cost Of Revenue $6.6M
Costof Goods And Services Sold $6.6M
Operating Income -$250M
Selling General And Administrative $165M
Research And Development $348M
Operating Expenses $514M
Investment Income Net -
Net Interest Income $55M
Interest Income $55M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.6M
Income Before Tax -$198M
Income Tax Expense $600K
Interest And Debt Expense -
Net Income From Continuing Operations -$199M
Comprehensive Income Net Of Tax -
Ebit -$250M
Ebitda -$244M
Net Income -$199M

Revenue & Profitability

Earnings Performance

ARVN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.1B
Total Current Assets $1.1B
Cash And Cash Equivalents At Carrying Value $101M
Cash And Short Term Investments $101M
Inventory -
Current Net Receivables $14M
Total Non Current Assets $24M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $939M
Other Current Assets $14M
Other Non Current Assets -
Total Liabilities $530M
Total Current Liabilities $230M
Current Accounts Payable $13M
Deferred Revenue -
Current Debt -
Short Term Debt $1.8M
Total Non Current Liabilities $300M
Capital Lease Obligations $9.1M
Long Term Debt $600K
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $9.7M
Other Current Liabilities $55M
Other Non Current Liabilities -
Total Shareholder Equity $562M
Treasury Stock -
Retained Earnings -$1.5B
Common Stock $100K
Common Stock Shares Outstanding $72M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$259M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.6M
Capital Expenditures $1.8M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $35M
Cashflow From Financing $7.9M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$199M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $263M
Total Revenue $263M
Cost Of Revenue $6.6M
Costof Goods And Services Sold $6.6M
Operating Income -$250M
Selling General And Administrative $165M
Research And Development $348M
Operating Expenses $514M
Investment Income Net -
Net Interest Income $55M
Interest Income $55M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.6M
Income Before Tax -$198M
Income Tax Expense $600K
Interest And Debt Expense -
Net Income From Continuing Operations -$199M
Comprehensive Income Net Of Tax -
Ebit -$250M
Ebitda -$244M
Net Income -$199M

ARVN News

ARVN Profile

Arvinas Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Arvinas, Inc. (ARVN) is a clinical-stage biopharmaceutical company focused on pioneering therapies that leverage their innovative PROTAC® technology to degrade disease-causing proteins, with a particular emphasis on oncology and other severe diseases. Headquartered in New Haven, Connecticut, Arvinas aims to address unmet medical needs through its proprietary approach to protein degradation, which holds the potential to create transformative treatments. The company is advancing a robust pipeline of product candidates, highlighting its commitment to improving patients' lives while capitalizing on the growing interest in targeted protein modulation within the biopharmaceutical sector.

VHAI
+66.66%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
BITF
+28.33%
$5.39
NVDA
+2.81%
$188.32
NVTS
+21.14%
$9.97
IONZ
-32.55%
$2.29
ASST
-30.54%
$1.08
BYND
-48.50%
$1.03
INTC
+2.33%
$37.22
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-10.39%
$0.43
QBTS
+23.01%
$40.61
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.13%
$11.54
CLF
+4.93%
$13.83
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
QS
+15.57%
$16.98
AMD
+0.70%
$216.42
SOFI
+3.62%
$27.14
ETHD
-12.82%
$3.33
CRML
+55.40%
$23.28
CIFR
+19.85%
$20.34
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
APLD
+0.73%
$34.24
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
NAK
+31.03%
$2.66
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
ONDS
+17.24%
$10.81
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IONQ
+16.19%
$82.09
IREN
+7.31%
$64.14
AVGO
+9.87%
$356.70
UAMY
+36.85%
$16.71
ABAT
+36.59%
$9.22
PFE
-0.20%
$24.73
KDLY
-1.56%
$0.85
NAKA
-1.56%
$0.85
SNAP
+3.47%
$8.05
RIG
+3.89%
$3.20
QUBT
+12.85%
$21.46
AAL
+1.90%
$11.74
UUUU
+16.86%
$23.77
NOK
-1.31%
$5.25
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
BMNR
+8.34%
$56.85
PLTR
+1.00%
$177.21
EPWK
-8.00%
$0.08
RMBL
+60.50%
$3.21
ADAP
-2.59%
$0.18
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
AAPL
+0.97%
$247.66
AMZN
+1.71%
$220.07
WULF
+3.62%
$14.00
XCH
+103.41%
$1.68
T
-1.08%
$25.59
ITP
+6.36%
$0.26
CLSK
+3.94%
$20.04
HPE
+1.63%
$24.80
RF
+1.65%
$24.56
NB
+8.95%
$11.32
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
GDXD
-13.62%
$0.73
BAC
+0.43%
$48.86
QSI
+24.55%
$2.08
KDP
+2.32%
$26.42
RGTZ
-50.00%
$9.30
VALE
+2.41%
$11.01
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
SLB
+1.73%
$32.27
ABEV
+1.42%
$2.14
BE
+26.52%
$109.91
WLGS
-5.57%
$0.04
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
TMQ
+10.62%
$6.56
GRAB
+1.19%
$5.93
GGB
+2.85%
$3.24
ETWO
0.00%
$3.30
VHAI
+66.66%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
BITF
+28.33%
$5.39
NVDA
+2.81%
$188.32
NVTS
+21.14%
$9.97
IONZ
-32.55%
$2.29
ASST
-30.54%
$1.08
BYND
-48.50%
$1.03
INTC
+2.33%
$37.22
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-10.39%
$0.43
QBTS
+23.01%
$40.61
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.13%
$11.54
CLF
+4.93%
$13.83
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
QS
+15.57%
$16.98
AMD
+0.70%
$216.42
SOFI
+3.62%
$27.14
ETHD
-12.82%
$3.33
CRML
+55.40%
$23.28
CIFR
+19.85%
$20.34
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
APLD
+0.73%
$34.24
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
NAK
+31.03%
$2.66
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
ONDS
+17.24%
$10.81
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IONQ
+16.19%
$82.09
IREN
+7.31%
$64.14
AVGO
+9.87%
$356.70
UAMY
+36.85%
$16.71
ABAT
+36.59%
$9.22
PFE
-0.20%
$24.73
KDLY
-1.56%
$0.85
NAKA
-1.56%
$0.85
SNAP
+3.47%
$8.05
RIG
+3.89%
$3.20
QUBT
+12.85%
$21.46
AAL
+1.90%
$11.74
UUUU
+16.86%
$23.77
NOK
-1.31%
$5.25
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
BMNR
+8.34%
$56.85
PLTR
+1.00%
$177.21
EPWK
-8.00%
$0.08
RMBL
+60.50%
$3.21
ADAP
-2.59%
$0.18
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
AAPL
+0.97%
$247.66
AMZN
+1.71%
$220.07
WULF
+3.62%
$14.00
XCH
+103.41%
$1.68
T
-1.08%
$25.59
ITP
+6.36%
$0.26
CLSK
+3.94%
$20.04
HPE
+1.63%
$24.80
RF
+1.65%
$24.56
NB
+8.95%
$11.32
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
GDXD
-13.62%
$0.73
BAC
+0.43%
$48.86
QSI
+24.55%
$2.08
KDP
+2.32%
$26.42
RGTZ
-50.00%
$9.30
VALE
+2.41%
$11.01
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
SLB
+1.73%
$32.27
ABEV
+1.42%
$2.14
BE
+26.52%
$109.91
WLGS
-5.57%
$0.04
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
TMQ
+10.62%
$6.56
GRAB
+1.19%
$5.93
GGB
+2.85%
$3.24
ETWO
0.00%
$3.30

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.